Found 19 matching trials
Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome PHASE3 Hemolytic and uremic syndrome (HUS) is a clinic-biological syndrome related...
Show More Learn More & Join Trial
Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHU PHASE3 The investigators aim to perform the first controlled randomized prospectiv...
Show More Location
University Hospital
Learn More & Join Trial
A Study to Compare SB12 (Proposed Eculizumab Biosimilar) to Soliris in Subjects With Paroxysmal Nocturnal Haemoglobinuria PHASE3 This is a randomised Phase III, double-blind, multicentre, cross-over study...
Show More Location
Fortis Memorial Research Institute
Learn More & Join Trial
Evaluation of Potential Predictors of Disease Progression in Participants With Atypical Hemolytic Uremic Syndrome (aHUS) Including Genetics, Biomarkers, and Treatment N/A This was a prospective, open-label study with no participant randomization....
Show More Location
Clinical Trial Site
Learn More & Join Trial
Study of NM8074 in Adult PNH Patients With Inadequate Response to Soliris PHASE2 This is a Phase II, open-label study designed to evaluate the safety, effic...
Show More Location
Multiple Locations
Learn More & Join Trial
Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD PHASE4 Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare autoimmune conditi...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS) PHASE2 This protocol is designed to collect safety and efficacy data on patients t...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Trial of BCD-148 and Soliris® for the Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria PHASE3 This clinical study is a randomized, open-label, international, multi-cente...
Show More Location
Federal State Budgetary Educational Institution of Higher Education "Academician I.P. Pavlov First St. Petersburg State Medical University" of the Ministry of Healthcare of Russian Federation
Learn More & Join Trial
Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris® PHASE1 A Double-blind, Randomized Clinical Study to Compare the Pharmacokinetics, ...
Show More Location
Limited Liability Company Research Center Eco-Bezopasnost (OOO Research Center Eco-Bezopasnost)
Learn More & Join Trial
Prospective Observational Study of Long-term Pathogenic Treatment of Elizaria® N/A This is prospective observational study of long-term pathogenic treatment o...
Show More Location
State budgetary healthcare institution "Chelyabinsk Regional Clinical Hospital"
Learn More & Join Trial